Clinical profile, treatment, and visual outcome of serpiginous choroiditis

Ocular Immunology and Inflammation

Volumn 15, Issue 4, 2007, Pages 325-335

  Abrez, H ^a   Biswas, Jyotirmay ^a   Sudharshan, S ^a  

^a MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

Corticosteroids; Geographic helicoid peripapillary choroiditis; Immunosuppressives; Serpiginous choroiditis

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHOROIDITIS; COHORT ANALYSIS; DATA ANALYSIS; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RECURRENT DISEASE; RETINA MACULOPATHY; RETROSPECTIVE STUDY; SCHOOL CHILD; SERPIGINOUS CHOROIDITIS; TERTIARY HEALTH CARE; VISION; VISUAL ACUITY; VISUAL DISORDER;

ADOLESCENT; ADULT; CHILD; CHOROIDITIS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 34548297387     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940701375162     Document Type: Article

References (27)

1. Schatz H, Maumenee AE, Partz A. Geographic helicoid peripapillary choroidopathy: clinical presentation and fluorescein angiographic findings. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:747-761.
2. Jampol LM, Orth D, Daily MJ, Rabb MF. Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979;88:683-689.
3. Gass JDM. Diseases causing choroidal exudative and hemorrhagic localized (disciform) detachment of the retina and pigment epithelium. In: Stereoscopic Atlas of the Macular Diseases: Diagnosis and Treatment, Vol 1, ed 4. St Louis: CV Mosby; 1997:158-164.
4. Blumenkranz MS, Gass DM, Clarkson JG. Atypical serpiginous choroiditis. Arch Ophthalmol. 1982;100:1773-1775.
5. Laatikainen L, Erkkila H. Serpiginous choroiditis. Br J Ophthalmol. 1974;58:777-783.
6. Schatz H, McDonald HR, Johnson RN. Geographic helicoid peripapillary choroidopathy (serpiginous choroiditis). In: Schachat AP, Murphy RB, eds. Retina, Vol 2, ed 2. St. Louis: CV Mosby;1994:1721-1728.
7. Bock CJ, Jampol LM. Serpiginous choroiditis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, Vol 2, ed 2. Philadelphia: WB Saunders; 2000:1307-1314.
8. Hamilton AM, Bird AC. Geographical choroidopathy. Br J Ophthalmol. 1974;58:784-797.
9. Nussenblatt RB, Palestine AG. Serpiginous choroidopathy. In: Nussenblatt RB, Palestine AG, eds. Uveitis: Fundamentals and Clinical Practice. Chicago:Year Book; 1989:309.
10. Hardy RA, Schatz H. Macular geographic helicoid choroidopathy. Arch Ophthalmol. 1987;105:1237-1242.
11. Wu JS, Lewis H, Fine SL, et al. Clinocopathological findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina. 1989;9:292-301.
12. Chisholm IH, Gass JDM, Hutton WL. The late stage of serpiginous (geographic) choroiditis. Am J Ophthalmol. 1976;82:343-351.
13. Mansour AM, Jampol LM, Packo KH, Hrisomalos NF. Macular serpiginous choroiditis. Retina. 1988;8:125-131.
14. Weiss H, Annesley WH Jr, Shields JA, Tomer T. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979;87:133-142.
15. Sahel JA, Weber M, Conlon MR, Albert DM. Pathology of the uveal tract. In: Albert DM, Jakobiec FA, eds. Principles and Practices of Ophthalmology: Clinical Practice. Philadelphia:WB Saunders; 1994:182:2145.
16. Laatikainen L, Erkkila H. Subretinal and disc neovascularization in serpiginous choroiditis. Br J Ophthalmol. 1982;66:326-331.
17. Wojno T, Meredith TA. Unusual findings in serpiginous choroiditis. Am J Ophthalmol. 1982;94:650-655.
18. Masi RJ, O'Connor GR, Kimura SJ. Anterior uveitis in geographic or serpiginous choroiditis. Am J Ophthalmol. 1978;86:228-232.
19. Ferris FL, Kaskoff A, Brenick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
20. Tom D, Yannuzzi LA. Serpiginous choroiditis. In: Guyer DR, Yannuzzi LA, Chang S, Shields JA, Green WR, eds. Retina, Vitreous, Macula, Vol 1. Philadelphia: WB Saunders: 1999; Chapter 44, pp. 553-564.
21. Laatikainen L, Erkkila H. A follow up study on serpiginous choroiditis. Acta Ophthalmol. 1981;59:707-718.
22. Gupta V, Agarwal A, Gupta A, Bambery P, Narang S. Clinical characteristics of serpiginous choroidopathy in North India. Am J Ophthalmol. 2002;134:47-56.
23. Gupta V, Gupta A, Arora S, Bambery P, Dogra MR, Agarwal A. Presumed tubercular serpiginous like choroiditis. Ophthalmology. 2003;110:1744-1749.
24. Priya K, Madhavan HN, Reiser BJ, et al. Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis: a polymerase chain reaction-based study. Ocul Immunol Inflamm. 2002;10:253-261.
25. Friberg T. Serpiginous choroiditis with branch vein occlusion and bilateral periphlebitis. Arch Ophthalmol. 1988;106:585-586.
26. Hoyng C, Tilanus M, Deutman A. Atypical central lesions in serpiginous choroiditis treated with oral prednisone. Graefes Arch Clin Exp Ophthalmol. 1998;236:154-156.
27. Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944-952.